Innovating cancer care access for low and middle-income countries
Dr Abdulkarim Ekzayez speaks to ecancer at the R4HC meeting at King's College London about the capacity to research health in conflict settings.
This project will look at not only the healthcare during conflict, the provision of health services during conflict, but also to determine what are the factors, the political and economic factors, that could affect the provision of healthcare in conflict settings. These determinants could define the way healthcare is designed and healthcare is delivered and accessed by populations affected by conflict.
In order to do this we need to understand the current capacity of researching health in conflict settings and then we need to identify the gaps in this capacity in order to know how to build this capacity in order to have better understanding of the determinants of healthcare in conflict.
Innovating cancer care access for low and middle-income countries
Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations
Key insights on breast cancer in Cape Verde
Prostate cancer
Rectal cancer
Special Issue on paediatric oncology
Synthetic biology and precision medicine in blood and gynaecological cancers
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC